Development of a serum biomarker panel predicting recurrence in stage i non-small cell lung cancer patients

Journal of Thoracic and Cardiovascular Surgery

Volumn 144, Issue 6, 2012, Pages 1344-1351

  Rinewalt, Daniel ^a   Shersher, David D ^a   Daly, Shaun ^a   Fhied, Cristina ^a   Basu, Sanjib ^a   Mahon, Brett ^a   Hong, Edward ^a   Chmielewski, Gary ^a   Liptay, Michael J ^a   Borgia, Jeffrey A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LOG RANK TEST; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING;

AGED; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; IMMUNOASSAY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84869088702     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.08.033     Document Type: Article

References (25)

1. American Cancer Society. Cancer facts and figures 2012. Available from: www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/ acspc-031941.pdf. Accessed April 21, 2012.
2. P.A. Groome, V. Bolejack, J.J. Crowley, C. Kennedy, M. Krasnik, and L.H. Sobin The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours J Thorac Oncol 2 2007 694 705
3. R.M. Flores, U.N. Ihekweazu, N. Rizk, J. Dycoco, M.S. Bains, and R.J. Downey Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer J Thorac Cardiovasc Surg 141 2009 59 64
4. B.E. Lee, D. von Haag, T. Lown, D. Lau, R. Calhoun, and D. Follette Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer J Thorac Cardiovasc Surg 133 2007 746 752
5. D.R. Aberle, A.M. Adams, C.D. Berg, W.C. Black, J.D. Clapp, and R.M. Fagerstrom Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409
6. J.A. Borgia, S. Basu, L.P. Faber, A.W. Kim, J.S. Coon, and K.A. Kaiser-Walters Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer J Thorac Oncol 4 2009 338 347
7. E.C. Farlow, M.S. Vercillo, J.S. Coon, S. Basu, A.W. Kim, and L.P. Faber A multi-analyte serum test for the detection of non-small cell lung cancer Br J Cancer 103 2010 1221 1228
8. K. Patel, E.C. Farlow, A.W. Kim, B.S. Lee, S. Basu, and J.S. Coon Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers Int J Cancer 129 2010 133 142
9. D.D. Shersher, M.S. Vercillo, C. Fhied, S. Basu, O. Rouhi, and B. Mahon Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer Ann Thorac Surg 92 2011 1805 1811
10. J. Vansteenkiste, C. Dooms, and P. De Leyn Early stage non-small-cell lung cancer: challenges in staging and adjuvant treatment: evidence-based staging Ann Oncol 21 Suppl. 7 2010 vii189 vii195
11. B. Goodgame, G.A. Pillot, Z. Yang, J. Shriki, B.F. Meyers, and J. Zoole Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer J Thorac Oncol 3 2008 130 134
12. S. Shiono, M. Abiko, and T. Sato Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers J Thorac Oncol 6 2011 43 47
13. M. Seike, N. Yanaihara, E.D. Bowman, K.A. Zanetti, A. Budhu, and K. Kumamoto Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier J Natl Cancer Inst 99 2007 1257 1269
14. M. Takada, M. Tada, E. Tamoto, A. Kawakami, K. Murakawa, and G. Shindoh Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer J Surg Res 122 2004 61 69
15. L. Xi, M.C. Coello, V.R. Litle, S. Raja, W.E. Gooding, and S.A. Yousem A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients Clin Cancer Res 12 2006 2484 2491
16. D.G. Beer, S.L. Kardia, C.C. Huang, T.J. Giordano, A.M. Levin, and D.E. Misek Gene-expression profiles predict survival of patients with lung adenocarcinoma Nat Med 8 2002 816 824
17. M. Raponi, Y. Zhang, J. Yu, G. Chen, G. Lee, and J.M. Taylor Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung Cancer Res 66 2006 7466 7472
18. K. Shedden, J.M. Taylor, S.A. Enkemann, M.S. Tsao, T.J. Yeatman, and W.L. Gerald Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study Nat Med 14 2008 822 827
19. J. Lin, and D.G. Beer Molecular predictors of prognosis in lung cancer Ann Surg Oncol 19 2012 669 676
20. R. Mitra, J. Lee, J. Jo, M. Milani, J.N. McClintick, and H.J. Edenberg Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model Clin Cancer Res 17 2011 2934 2946
21. G. Chen, S. Kim, J.M. Taylor, Z. Wang, O. Lee, and N. Ramnath Development and validation of a quantitative real-time polymerase chain reaction classifier for lung cancer prognosis J Thorac Oncol 6 2011 1481 1487
22. M. Reck, A. Hermes, E.H. Tan, E. Felip, B. Klughammer, and J. Baselga Tissue sampling in lung cancer: a review in light of the MERIT experience Lung Cancer 74 2011 1 6
23. E. Thunnissen, K.M. Kerr, F.J. Herth, S. Lantuejoul, M. Papotti, and R.C. Rintoul The challenge of NSCLC diagnosis and predictive analysis on small samples: practical approach of a working group Lung Cancer 76 2011 1 18
24. T.A. D'Amico, K.R. Brooks, M.B. Joshi, D. Conlon, J. Herndon II, and R.P. Petersen Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection Ann Thorac Surg 81 2006 1982 1987
25. A.N. Shoushtari, R.Z. Szmulewitz, and C.W. Rinker-Schaeffer Metastasis-suppressor genes in clinical practice: lost in translation? Nat Rev Clin Oncol 8 2011 333 342